Back to search

Article

Abnormal lymphatic S1P signaling aggravates lymphatic dysfunction and tissue inflammation

2023-06-12

Abstract excerpt

<h4>BACKGROUND</h4> Lymphedema is a global health problem with no effective drug treatment. Enhanced T cell immunity and abnormal lymphatic endothelial cell (LEC) signaling are promising therapeutic targets for this condition. Sphingosine-1-phosphate (S1P) mediates a key signaling pathway required for normal LEC function, and altered S1P signaling in LECs could lead to lymphatic disease and pathogenic T cell activ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7fb8f1f3-9b14-5f0a-87c6-b4d1efe37222
DOI
10.1101/2023.06.08.23291175
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Abnormal lymphatic S1P signaling aggravates lymphatic dysfunction and tissue inflammationDOI 10.1101/2023.06.08.23291175
Select a neighboring publication to make it the new centre.